Biocidal products must be phased off the NI market The active substance/product type combinations listed below are due to expire under the EU Biocidal Products Regulation (EU BPR) on the following date. This affects NI: 30 June 2025 - 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product types 7 and 10
Once the approvals expire, the active substance will no longer be able to be used in biocidal products of the relevant product types in NI. In addition articles treated with such products will no longer be able to be placed on the market in NI.
If you hold an affected EU BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision. If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us. Active substance expiry dates postponed whilst the renewal evaluation is completed in the EU For reasons beyond the control of the applicants, the approvals of the active substance/product type combinations listed below were likely to expire before a decision could be taken on their renewal under the EU BPR. To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry dates of the following approvals. This affects NI: From 31 January 2025 to 31 July 2026
From 31 January 2025 to 31 January 2027
From 31 March 2025 to 30 September 2027
If you want to supply new biocidal products containing these active substances, you can still apply for EU BPR product authorisation. New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE will provide separate updates on the renewal decisions when relevant. | 
